Monica Terenziani

Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 130 publications

Psychosocial, Neuropsychological, Academic, and Social Outcomes in Pediatric Solid Tumor Survivors: An Exploratory Parent-Reported Study.

Psychosocial, Neuropsychological, Academic, and Social Outcomes in Pediatric Solid Tumor Survivors: An Exploratory Parent-Reported Study.

Journal: Children (Basel, Switzerland)

Published: June 11, 2026

The VIVA Regimen (Vinorelbine, Ifosfamide, Vincristine, and Actinomycin-D) for High-Risk Rhabdomyosarcoma: Feasibility and Outcomes From a Single-Institution Study.

The VIVA Regimen (Vinorelbine, Ifosfamide, Vincristine, and Actinomycin-D) for High-Risk Rhabdomyosarcoma: Feasibility and Outcomes From a Single-Institution Study.

Journal: Pediatric blood & cancer

Published: April 07, 2026

Bereavement in paediatric oncology: programme evaluation.

Bereavement in paediatric oncology: programme evaluation.

Journal: BMJ supportive & palliative care

Published: January 20, 2026

Cancer treatments-related factors for subsequent soft-tissue sarcoma in childhood cancer survivors.

Cancer treatments-related factors for subsequent soft-tissue sarcoma in childhood cancer survivors.

Journal: ESMO open

Published: January 14, 2026

Long-term adverse effects of modern Wilms tumour therapies: implications for monitoring.

Long-term adverse effects of modern Wilms tumour therapies: implications for monitoring.

Journal: Nature reviews. Urology

Published: January 09, 2026

Risk of Subsequent Primary Melanoma in 68,002 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup cohort study.

Risk of Subsequent Primary Melanoma in 68,002 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup cohort study.

Journal: Journal of the National Cancer Institute

Published: November 13, 2025

Risk of subsequent primary melanoma in 68 002 five-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup cohort study.

Risk of subsequent primary melanoma in 68 002 five-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup cohort study.

Journal: Journal of the National Cancer Institute

Published: November 13, 2025

Pediatric palliative care in patients with brain tumors: Timing, activation, and management of acute events.

Pediatric palliative care in patients with brain tumors: Timing, activation, and management of acute events.

Journal: Tumori

Published: October 22, 2025

Risk Factors for Valvulopathy Among Childhood Cancer Survivors.

Risk Factors for Valvulopathy Among Childhood Cancer Survivors.

Journal: JAMA oncology

Published: October 09, 2025

Endocrine late-effects in survivors of childhood and adolescence cancer: clinical management.

Endocrine late-effects in survivors of childhood and adolescence cancer: clinical management.

Journal: Journal of endocrinological investigation

Published: August 13, 2025

Long-Term Remission of a Pediatric Vaginal Yolk Sac Tumor and Adult-Onset Recurrence.

Long-Term Remission of a Pediatric Vaginal Yolk Sac Tumor and Adult-Onset Recurrence.

Journal: Pediatric blood & cancer

Published: June 26, 2025

Management of ovarian granulosa cell tumor in childhood: a case report and recommendations for a multidisciplinary approach.

Management of ovarian granulosa cell tumor in childhood: a case report and recommendations for a multidisciplinary approach.

Journal: Frontiers in oncology

Published: May 23, 2025

Showing 1-12 of 130

Last Updated: 09/26/2026